| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $798K | -61.5% |
| SG&A Expense | $5.1M | -3.4% |
| Operating Income | -$14.2M | -18.1% |
| Interest Expense | $2K | +2434.6% |
| Pre-tax Income | -$14.2M | -19.1% |
| Income Tax | -$32K | -109.8% |
| Net Income | -$13.8M | -10.5% |
| EPS (Diluted) | -$1.45 | +62.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23K | -99.6% |
| Current Assets | $32K | -99.7% |
| Total Assets | $2.7M | -80.8% |
| Current Liabilities | $1.5M | +265.6% |
| Total Liabilities | $2.7M | +33.4% |
| Stockholders' Equity | -$282K | -103.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.7M | +57.1% |
| Capital Expenditures | $14K | +0.0% |
| Investing Cash Flow | -$650K | +87.5% |
| Financing Cash Flow | $1.2M | -94.9% |
| Free Cash Flow | -$5.7M | +57.0% |